Ocular Therapeutix OCUL Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Based on trailing twelve months.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's gross margin?
- Ocular Therapeutix (OCUL) reported gross margin of 87.2% in Q1 2026.
- How has Ocular Therapeutix's gross margin changed year-over-year?
- Ocular Therapeutix's gross margin decreased by 3.8% year-over-year, from 90.7% to 87.2%.
- What is the long-term trend for Ocular Therapeutix's gross margin?
- Over 5 years (2020 to 2025), Ocular Therapeutix's gross margin has grown at a -0.2% compound annual growth rate (CAGR), from 88% to 87.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.